President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...
On Capitol Hill, one of President Trump’s most consequential and controversial nominees made his case for the top job at the ...
If he is confirmed as Health and Human Services secretary, Robert F. Kennedy Jr. would take over a sprawling bureaucracy with ...
Amid a deluge of executive actions, the Trump administration has directed federal health agencies to pause external ...
A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name Journavx ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...
Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has ...